Gestational Trophoblastic Neoplasia Clinical Trials

8 recruiting

Gestational Trophoblastic Neoplasia Trials at a Glance

9 actively recruiting trials for gestational trophoblastic neoplasia are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Hangzhou, Beijing, and Bordeaux. Lead sponsors running gestational trophoblastic neoplasia studies include Peking Union Medical College Hospital, Women's Hospital School Of Medicine Zhejiang University, and Hospices Civils de Lyon.

Browse gestational trophoblastic neoplasia trials by phase

Treatments under study

About Gestational Trophoblastic Neoplasia Clinical Trials

Looking for clinical trials for Gestational Trophoblastic Neoplasia? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gestational Trophoblastic Neoplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gestational Trophoblastic Neoplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Hydatidiform MoleGestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University30 enrolled1 locationNCT03785574
Recruiting
Phase 2

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital70 enrolled1 locationNCT05139095
Recruiting

The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment

Gestational Trophoblastic Neoplasia
Sheffield Teaching Hospitals NHS Foundation Trust20 enrolled1 locationNCT06169644
Recruiting
Not Applicable

Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6

Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital40 enrolled1 locationNCT06028672
Recruiting
Phase 2

Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7

Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital17 enrolled1 locationNCT06020755
Recruiting

Clinical Specialty Queue For Gestational Trophoblastic Neoplasia

Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University1,000 enrolled1 locationNCT06681259
Recruiting
Phase 2

A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Gestational Trophoblastic NeoplasiaGestational Trophoblastic DiseaseGestational Trophoblastic Tumor, Recurrent
Imperial College London20 enrolled1 locationNCT05635344
Recruiting
Phase 1Phase 2

Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment

Gestational Trophoblastic Neoplasias (GTN)
Hospices Civils de Lyon26 enrolled9 locationsNCT04396223
Recruiting
Phase 2

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University20 enrolled1 locationNCT04812002